Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Asia Pharmaceutical is a prominent Chinese pharmaceutical group specializing in the research, development, manufacturing, and marketing of over-the-counter (OTC) and prescription drugs. The company is best known for its flagship brand, Kuai Ke, which is one of the most recognized cold and flu medications in the Chinese market. Its extensive product portfolio covers multiple therapeutic areas, including respiratory health, pediatrics, gastroenterology, and cardiovascular medicine. Hainan Asia Pharmaceutical operates several large-scale manufacturing bases across China and maintains a robust distribution network serving both retail pharmacies and hospitals. The company integrates modern pharmaceutical science with traditional Chinese medicine to provide a diverse range of healthcare solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Asia Pharmaceutical.